7NA6 image
Deposition Date 2021-06-19
Release Date 2021-09-29
Last Version Date 2024-06-05
Entry Detail
PDB ID:
7NA6
Keywords:
Title:
Cryo-EM structure of AAV True Type
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.35 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP1
Gene (Uniprot):cap
Chain IDs:A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z, AA (auth: a), BA (auth: b), CA (auth: c), DA (auth: d), EA (auth: e), FA (auth: f), GA (auth: g), HA (auth: h), IA (auth: i), JA (auth: j), KA (auth: k), LA (auth: l), MA (auth: m), NA (auth: n), OA (auth: o), PA (auth: p), QA (auth: q), RA (auth: r), SA (auth: s), TA (auth: t), UA (auth: u), VA (auth: v), WA (auth: w), XA (auth: x), YA (auth: y), ZA (auth: z), AB (auth: 1), BB (auth: 2), CB (auth: 3), DB (auth: 4), EB (auth: 5), FB (auth: 6), GB (auth: 7), HB (auth: 8)
Chain Length:517
Number of Molecules:60
Biological Source:Adeno-associated virus
Ligand Molecules
Primary Citation
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2.
J.Struct.Biol. 213 107795 107795 (2021)
PMID: 34509611 DOI: 10.1016/j.jsb.2021.107795

Abstact

Adeno-associated viruses (AAV) are utilized as gene transfer vectors in the treatment of monogenic disorders. A variant, rationally engineered based on natural AAV2 isolates, designated AAV-True Type (AAV-TT), is highly neurotropic compared to wild type AAV2 in vivo, and vectors based on it, are currently being evaluated for central nervous system applications. AAV-TT differs from AAV2 by 14 amino acids, including R585S and R588T, two residues previously shown to be essential for heparan sulfate binding of AAV2. The capsid structures of AAV-TT and AAV2 visualized by cryo-electron microscopy at 3.4 and 3.0 Å resolution, respectively, highlighted structural perturbations at specific amino acid differences. Differential scanning fluorimetry (DSF) performed at different pH conditions demonstrated that the melting temperature (Tm) of AAV2 was consistently ∼5 °C lower than AAV-TT, but both showed maximal stability at pH 5.5, corresponding to the pH in the late endosome, proposed as required for VP1u externalization to facilitate endosomal escape. Reintroduction of arginines at positions 585 and 588 in AAV-TT caused a reduction in Tm, demonstrating that the lack of basic amino acids at these positions are associated with capsid stability. These results provide structural and thermal annotation of AAV2/AAV-TT residue differences, that account for divergent cell binding, transduction, antigenic reactivity, and transduction of permissive tissues between the two viruses. Specifically, these data indicate that AAV-TT may not utilize a glycan receptor mediated pathway to enter cells and may have lower antigenic properties as compared to AAV2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures